Silo Pharma (SILO) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to -$1.1 million.
- Silo Pharma's Profit After Tax fell 1955.44% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.1 million, marking a year-over-year decrease of 3418.46%. This contributed to the annual value of -$4.4 million for FY2024, which is 1870.46% down from last year.
- According to the latest figures from Q3 2025, Silo Pharma's Profit After Tax is -$1.1 million, which was down 1955.44% from -$1.2 million recorded in Q2 2025.
- Silo Pharma's 5-year Profit After Tax high stood at $6.5 million for Q3 2021, and its period low was -$1.7 million during Q4 2024.
- Over the past 5 years, Silo Pharma's median Profit After Tax value was -$931779.0 (recorded in 2024), while the average stood at -$596385.5.
- The largest annual percentage gain for Silo Pharma's Profit After Tax in the last 5 years was 112121.95% (2021), contrasted with its biggest fall of 28961.56% (2021).
- Quarter analysis of 5 years shows Silo Pharma's Profit After Tax stood at -$1.1 million in 2021, then tumbled by 56.46% to -$1.7 million in 2022, then soared by 32.57% to -$1.1 million in 2023, then plummeted by 54.36% to -$1.7 million in 2024, then soared by 35.84% to -$1.1 million in 2025.
- Its Profit After Tax was -$1.1 million in Q3 2025, compared to -$1.2 million in Q2 2025 and -$1.0 million in Q1 2025.